Primary Retroperitoneal Lymph Node Dissection in Low-stage Testicular Germ Cell Tumors: A Detailed Pathologic Study With Clinical Outcome Analysis With Special Emphasis on Patients Who Did Not Receive Adjuvant Therapy-Reference-Cited by-同舟云学术

Primary Retroperitoneal Lymph Node Dissection in Low-stage Testicular Germ Cell Tumors: A Detailed Pathologic Study With Clinical Outcome Analysis With Special Emphasis on Patients Who Did Not Receive Adjuvant Therapy

Published:2013-12 Issue:6 Volume:82 Page:1341-1347
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Al-Ahmadie Hikmat A.,Carver Brett S.,Cronin Angel M.,Olgac Semra,Tickoo Satish K.,Fine Samson W.,Gopalan Anuradha,Stasi Jason,Rabbani Farhang,Bosl George J.,Sheinfeld Joel,Reuter Victor E.

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Testicular germ-cell cancer;Bosl;N Engl J Med,1997

2. The role of retroperitoneal lymph node dissection in the management of testicular cancer;Stephenson;Urol Oncol,2004

3. The pathology of late recurrence of testicular germ cell tumors;Michael;Am J Surg Pathol,2000

4. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse;Rabbani;J Clin Oncol,2001

5. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy;Kondagunta;J Clin Oncol,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Die primäre retroperitoneale Lymphadenektomie beim testikulären Keimzelltumor im klinischen Stadium IIA/B – Renaissance einer etablierten Therapie?;Die Urologie;2024-09-13

2. Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection;Urologic Oncology: Seminars and Original Investigations;2024-08

3. Primary retroperitoneal lymph node dissection for metastatic non‐seminomatous germ cell tumours: outcomes and adjuvant chemotherapy;BJU International;2024-07-05

4. Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor—N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?;Journal of Clinical Oncology;2022-11-10

5. Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review;European Urology Focus;2022-11